Children with eczema between the ages of six months and six years benefit from treatment with dupilumab, according to the results of a...

New research has identified an immune biomarker in newborns that may predict the onset and severity of pediatric AD.

According to a recent study, photoaggravated AD severely impacts quality of life for patients.

According to a recent study, children are more likely to have AD in the first two years of life if their parents have AD or asthma.

New findings suggest that combining routine pediatric care with teleconsultation and email newsletters to parents appears to effectively...

Patients with both asthma and atopic dermatitis (AD) are at a higher risk of hospitalization than patients with only one of the...

Dietary changes may improve symptoms in patients with mild or moderate AD when used in conjunction with regular treatment.

Taking vitamin D supplements during pregnancy may reduce the likelihood of infants developing AD in their first year of life.